Skip to main content

Table 2 Baseline characteristics of the study patients

From: Mid- and long-term efficacy of surgical treatment of Vancouver B2 and B3 periprosthetic femoral fractures

Classification

B2

B3

Total

Number

69(83%)

14(17%)

83(100%)

Gender (female/male)

38/31

9/5

 

Age (years)

63.4 ± 9.1

66.4 ± 11.3

63.9 ± 9.5

Stem before revision

 uncemented

47(57%)

7(8%)

54(65%)

 cemented stem

22(27%)

7(8%)

29(35%)

Injury mechanism

 mild trauma

59(71%)

5(6%)

64(77%)

 immense trauma

6(7%)

7(8%)

13(15%)

 unknown cause

4(5%)

2(3%)

6(8%)

Comorbidities (principal)

 Cardiovascular diseases

27(33%)

7(8%)

34(41%)

 Respiratory diseases

15(18%)

3(4%)

18(22%)

 Endocrine diseases

9(11%)

2(3%)

11(14%)

 Other

7(8%)

2(3%)

9(11%)

 ASA1

5(6%)

0

5(6%)

 ASA2

12(14%)

2(3%)

14(17%)

 ASA3

32(39%)

7(8%)

39(47%)

 ASA4

20(24%)

5(6%)

25(30%)

 SF-36 (Pre)

28.6 ± 10.4

31.0 ± 12.3

29.0 ± 10.7